Every merger, amalgamation, and scheme of arrangement in India ultimately reduces to a single number: the swap ratio — the rate at which shareholders of the transferor company exchange their existing shares for shares of the resulting company. Get this number right and the merger proceeds with shareholder confidence, regulatory clearance, and NCLT approval. Get it wrong — or allow management to determine it without independent oversight — and the consequences range from investor litigation and SEBI observations to scheme rejection by the National Company Law Tribunal.
Swap ratio determination in India sits at the intersection of financial Valuation theory, regulatory compliance, and corporate governance. It requires the application of at least three recognised Valuation methodologies — Discounted Cash Flow, Comparable Company Multiples, and Net Asset Value — to both companies, the derivation of a defensible per-share value for each, and the calculation of an exchange ratio that is fair to shareholders on both sides. For listed companies, the process additionally involves stock exchange filing, SEBI no-objection, and an independent fairness opinion. For unlisted companies, NCLT is the final arbiter of scheme fairness — making the quality of the independent Valuation report the primary determinant of whether the scheme proceeds or is challenged.
At Elite Valuation, our IBBI-registered valuers have delivered share exchange ratio Valuation reports for mergers and amalgamations across manufacturing, financial services, technology, real estate, and infrastructure sectors — providing the independent, methodology-based, and documentation-rich outputs that regulators, NCLT, and institutional shareholders require. This guide covers every dimension of swap ratio determination in India: the regulatory framework, the Valuation methodology, the step-by-step process, the worked numerical example, the common errors, and the SEBI compliance requirements for listed company schemes.
Key Takeaways: Swap Ratio Determination India
- A swap ratio is the number of resulting company shares issued for each transferor company share — determined through independent Valuation of both entities under Sections 230–232 of the Companies Act, 2013
- The IBBI-registered valuer must apply all three Valuation approaches — Income (DCF), Market (CCM), and Asset (NAV) — and document the basis for weighting each method in the final per-share conclusion
- For listed companies, SEBI and the stock exchanges must review and issue a no-objection letter on the scheme before it proceeds to NCLT — making the fairness of the swap ratio subject to regulatory scrutiny before shareholder vote
- The swap ratio formula is: per-share fair value of transferor company ÷ per-share fair value of resulting company — both derived from independent Valuation on the same reference date
- Fractional shares arising from the applied exchange ratio must be addressed in the scheme document, typically via cash payment for fractional entitlements at the determined per-share value
- SEBI's primary concern in reviewing listed company schemes is the fairness of the swap ratio to public shareholders — inadequate or conflicted valuations are the most common basis for SEBI raising observations on draft schemes
- Our IBBI-registered valuers produce merger Valuation reports that comply with IBBI Valuation Standards, satisfy SEBI and stock exchange requirements, and are defensible before NCLT in contested proceedings
What Is Swap Ratio in a Merger in India?
A swap ratio — also referred to as a share exchange ratio — is the number of shares of the resulting or acquiring company that are issued to each shareholder of the transferor or target company for every share they hold, in exchange for the surrender of their existing shareholding. It is the fundamental economic translation mechanism in any merger or amalgamation: it determines how ownership in the combined entity is distributed between the two pre-merger shareholder bases.
📌 Quick Definition
Swap ratio in India is the share exchange rate in a merger, amalgamation, or scheme of arrangement — expressed as the number of resulting company shares issued per transferor company share. It is calculated by dividing the independently determined per-share fair value of the transferor company by the per-share fair value of the resulting company, and is subject to IBBI-registered valuer certification, SEBI review (for listed companies), and NCLT approval under Sections 230–232 of the Companies Act, 2013.
The swap ratio is not the same as a cash acquisition price — there is no rupee payment to shareholders. Instead, transferor shareholders become shareholders in the resulting company, and their economic participation in the merged entity is determined entirely by the swap ratio. If the exchange ratio undervalues the transferor company relative to the resulting company, transferor shareholders receive a smaller proportionate interest in the combined entity than they are economically entitled to. If it overvalues the transferor company, resulting company's existing shareholders are diluted beyond what is justified. Both outcomes cause investor harm — which is precisely why independent Valuation by a qualified professional is a legal and regulatory requirement, not a procedural formality.
📋 Regulatory Anchor: Swap ratio determination in India is governed by Sections 230–232 of the Companies Act, 2013 (scheme of arrangement), the Companies (Registered Valuers and Valuation) Rules, 2017, SEBI's Circular on Schemes of Arrangement for Listed Companies, and SEBI's LODR Regulations 2015. All valuations must be performed on the same reference date for both companies.
🎁 Get the Free M&A Valuation Guide
Download our complete M&A Valuation Playbook - covering DCF, comparable company analysis, precedent transactions, and swap ratio methodology for Indian deals. Free; no sign-up required.
What Is the Regulatory Framework for Swap Ratios?
The regulatory architecture governing merger exchange ratio determination in India involves multiple overlapping frameworks — each with its own requirements and the potential to delay or derail a scheme if not properly managed. Understanding the complete regulatory map is the starting point for every merger transaction.
Companies Act, 2013 — Sections 230–232
The foundational legal instrument for mergers and amalgamations in India. Section 230 enables companies to propose schemes of compromise or arrangement with their creditors or members. Section 232 specifically governs mergers and amalgamations, requiring: a report by the board of directors on the effect of the scheme on shareholders and creditors; an independent Valuation report establishing the swap ratio; disclosure of the Valuation methodology in the Explanatory Statement; and approval of the scheme by a majority of shareholders (representing 75% in value) in each class, followed by NCLT sanction.
SEBI Circular on Schemes of Arrangement
For listed companies, SEBI's Circular (most recently updated in 2020) mandates that any draft scheme involving a listed entity must be filed with the stock exchanges before NCLT proceedings commence. The exchanges review the scheme — including the exchange ratio — and forward it to SEBI. SEBI issues either a no-objection letter or raises specific observations. SEBI's review focuses on the fairness of the swap ratio to public shareholders, the independence of the Valuation, and whether the scheme creates any structure that disproportionately benefits promoters at the expense of public shareholders.
SEBI LODR Regulations 2015 — Regulation 37
Regulation 37 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015 requires every listed entity to submit a draft scheme to the stock exchanges for prior approval before filing with the NCLT. This creates a mandatory pre-NCLT regulatory review step that is specific to listed companies. The stock exchange review timeline is typically 30–45 days, during which the exchange's panel of independent valuers or investment bankers assesses the fairness of the exchange ratio.
IBBI Valuation Rules and Standards
The Companies (Registered Valuers and Valuation) Rules, 2017 specify that Valuation in connection with schemes of arrangement under the Companies Act must be performed by an IBBI-registered valuer in the Securities or Business Valuation asset class. The IBBI Valuation Standards strongly recommend that the valuer apply all recognised approaches, document the basis for method selection and weighting, and produce a report that meets the professional standards of the IBBI. A Valuation report that is not signed by an IBBI-registered valuer is not compliant with the Companies Act requirement for merger schemes.
| Regulatory Instrument | Issued By | Key Requirement for Swap Ratio | Applicability |
|---|---|---|---|
| Companies Act, 2013 — Sections 230–232 | MCA | Independent valuation report; disclosure in explanatory statement; 75% shareholder approval; NCLT sanction | All Companies |
| Companies (Registered Valuers) Rules, 2017 | IBBI | Mandatory IBBI-registered valuer; adherence to valuation standards; multi-approach valuation recommended | All Companies |
| SEBI Circular on Schemes (2020) | SEBI | Draft scheme submission to stock exchanges; SEBI no-objection on swap ratio; independent fairness opinion review | Listed Companies |
| SEBI LODR Regulation 37 | SEBI | Prior stock exchange approval before NCLT filing; review timeline typically 30–45 days | Listed Companies |
| IBBI Valuation Standards | IBBI | Recommended three-approach framework; documentation standards; independence and professional conduct requirements | All Valuers |
| Income Tax Act — Section 2(19AA) / 2(1B) | CBDT | Tax neutrality conditions for mergers/demergers; swap ratio must align with scheme eligibility under Section 72A and related provisions | All Companies |
⚠ Critical Compliance Point: SEBI has raised specific observations in multiple listed company schemes where the Valuation was conducted by a firm with a prior advisory relationship with one of the merging companies, or where the exchange ratio appeared favourable to the promoter group at the expense of public shareholders. Independence of the Valuation is not merely a regulatory checkbox — it is the primary protection for minority shareholders and the central question in any contested scheme proceeding. Our SEBI Valuation Services and Company Valuation Services are structured to meet this independence standard in full. For cross-border mergers involving foreign shareholders or overseas subsidiaries, see our FEMA Valuation guide for the additional compliance requirements under foreign exchange regulations. For the complete regulatory framework governing listed company Valuations, see our SEBI Valuation guide.
How Is the Swap Ratio Formula Applied?
The swap ratio formula is deceptively simple — but its inputs require the full rigour of a formal independent Valuation of both companies. The formula itself is applied only after each company's per-share fair value has been independently determined through the three-approach Valuation framework recommended under IBBI best practice.
📌 Swap Ratio Formula
Swap Ratio = Per-Share Fair Value of Transferor Company ÷ Per-Share Fair Value of Resulting Company
This ratio expresses the number of resulting company shares to be issued for each transferor company share. A ratio of 3:1 means 3 resulting company shares are issued for every 1 transferor company share surrendered.
For fractional outputs (e.g., 2.67:1), the scheme document must specify how fractional share entitlements are resolved — typically via cash payment at the per-share value of the resulting company.
Swap Ratio — Step-by-Step Derivation
Step 1: Value Transferor Company (Company A)
Per-share value (A) = Weighted average of:
DCF 40–50%
CCM 30–40%
NAV 15–25%
Step 2: Value Resulting Company (Company B)
Per-share value (B) = Weighted average of:
DCF 40–50%
CCM 30–40%
NAV 15–25%
Step 3: Calculate Swap Ratio
Swap Ratio = Per-share value (A) ÷ Per-share value (B)
Step 4: Cross-Check Against Market Price
For listed companies — compare implied exchange ratio vs. 30‑day, 60‑day and 90‑day VWAP ratio of both companies' shares.
Step 5: Validate Against EPS & Book Value
EPS ratio EPS (A) ÷ EPS (B)
BV ratio BVPS (A) ÷ BVPS (B)
Sanity checks only — not primary determinants.
Why the Same Reference Date Is Non-Negotiable
The Valuation of both companies must be performed as of the same reference date — typically the date of the board resolution approving the merger, or a date specifically defined in the scheme. Valuing Company A as of December 31 and Company B as of March 31 produces an exchange ratio that is economically incoherent — it mixes financial positions, market conditions, and performance data from different periods. SEBI inspectors and NCLT have specifically flagged reference date mismatches as a material deficiency in merger Valuation reports, and such mismatches are grounds for scheme objection.
What Methods Determine Swap Ratio Valuation?
Best practice — and the expectation of SEBI and NCLT — is that all three recognised Valuation approaches are applied to each company in a swap ratio engagement: the Income Approach (DCF), the Market Approach (CCM), and the Asset Approach (NAV). The final per-share value for each company is derived by assigning appropriate weights to the outputs of each method, based on the company's nature, sector, profitability and the quality of available evidence. Applying only one method, or assigning arbitrary weights without documented justification, is a methodological failure that will not survive SEBI or NCLT scrutiny.
Method 1 — Discounted Cash Flow (Income Approach)
Primary for Profitable Businesses
IBBI — Income Approach
The DCF method projects the free cash flows of each company over a 5–7 year explicit period, discounts them at the company's Weighted Average Cost of Capital (WACC), and adds a terminal value capturing all cash flows beyond the explicit period. The output is Enterprise Value, which is then bridged to per-share Equity Value by deducting net debt and dividing by total diluted shares. DCF is the primary method for profitable, cash-generative businesses with a reliable projection horizon — manufacturing companies, financial services firms, and established consumer businesses. For our DCF methodology and worked example for Indian companies, see our complete DCF Valuation Guide.
Method 2 — Comparable Company Multiples (Market Approach)
Market-Anchored Cross-Check
IBBI — Market Approach
The CCM method applies sector-specific trading multiples — EV/EBITDA, EV/Revenue, P/E — derived from listed comparable companies to each merging company's financial metrics. The listed peer multiples provide a market-anchored reference point: they reflect what market participants are currently paying for businesses with similar sector exposure, growth profile, and profitability. For unlisted companies, a Discount for Lack of Marketability (DLOM) of 15–30% is applied to the CCM-indicated value to account for the absence of a liquid market. The CCM method is strongest when clear listed peers exist with positive EBITDA — for early-stage or highly specialised businesses, peer selection becomes challenging and method weighting shifts toward DCF or NAV.
Method 3 — Net Asset Value (Asset Approach)
Primary for Asset-Heavy Entities
IBBI — Asset Approach
The NAV method values each company based on the fair value of its assets minus its liabilities at the reference date. For the NAV approach to be meaningful, each significant asset must be independently appraised — land and buildings at current market rates, plant and equipment at replacement value or market value, investments at fair value, and intangibles such as brands and patents at independently assessed values. The NAV method is the primary approach for holding companies, real estate developers, infrastructure companies, and investment vehicles — where the earning capacity of the business is directly linked to the value of specific assets rather than an ongoing operating cash flow stream. For companies with significant intangible assets, our Intangible Asset Valuation Guide covers the specialist approaches required..
How Are the Three Methods Weighted?
The weighting of the three approaches is not formulaic — it requires professional judgment based on the specific characteristics of each company being valued. The IBBI-registered valuer must document the rationale for the assigned weights in the Valuation report. Common weighting frameworks by company type are illustrated below:
| Company Type | DCF Weight | CCM Weight | NAV Weight | Rationale |
|---|---|---|---|---|
| Profitable Manufacturing / FMCG | 45–50% | 35–40% | 10–15% | Reliable cash flows; clear listed peers; low asset intensity |
| Technology / SaaS (Pre-EBITDA) | 35–40% | 40–45% | 10–15% | DCF projection uncertainty high; EV/Revenue CCM more reliable |
| Real Estate Developer | 20–25% | 20–25% | 50–60% | Asset value dominates; project NAV is the standard market metric |
| Holding / Investment Company | 10–15% | 15–20% | 65–75% | Intrinsic value is portfolio fair value; no independent operations |
| Financial Services / NBFC | 30–35% | 35–40% | 25–30% | Book value multiples highly relevant; P/BV CCM anchors valuation |
| Infrastructure / Utilities | 45–55% | 20–25% | 25–30% | Long-term contracted cash flows; limited peer liquidity; asset base material |
How Is Swap Ratio Calculated? 8-Step Process
A compliant share exchange ratio determination follows a structured eight-step process — from engagement inception through to the final report submitted to NCLT and regulatory authorities. Every step must be documented, and the report must be capable of being reproduced from the documentation alone.
1. Mandate Definition and Valuation Date Setting
Define the exact scope of the engagement: both companies to be valued, the reference date (typically the date of the board resolution approving the merger or a defined date in the scheme), the purpose of the Valuation (scheme of arrangement under Section 232), and the regulatory context (listed or unlisted companies; whether SEBI review applies). Obtain the draft scheme of arrangement and review its provisions before commencing Valuation — the scheme's capital structure mechanics, merger ratio mechanics, and treatment of outstanding convertible instruments all affect the per-share value derivation.
2. Independence and Conflict-of-Interest Assessment
The IBBI-registered valuer must assess and document the absence of any conflict of interest with either company, their promoters, their respective boards, and any significant shareholders. This includes reviewing prior advisory mandates, common directorships, audit relationships, and any economic interest in the transaction outcome. SEBI is particularly vigilant about conflicts — a valuer who has previously advised either company on deal structuring, financing, or business strategy cannot be considered independent for merger Valuation purposes. The independence declaration must be signed and retained in the working file.
3. Data Collection — Both Companies
Issue a structured information request covering both entities: audited financial statements for the last 3–5 years; management accounts and projections; detailed fixed asset schedules; capital structure details including convertible instruments, ESOPs, and warrants outstanding; material contracts, licences, and regulatory approvals; any prior independent Valuations; and, for listed companies, the share price history and volume data for VWAP calculation. For asset-heavy companies, independent asset appraisal reports for land, buildings, and plant must be obtained or commissioned separately from the Valuation exercise.
4. Independent Valuation of Each Company
Apply all three Valuation approaches — DCF, CCM, and NAV — independently to each company. This is effectively two separate, full-scope Valuation exercises conducted in parallel. The same peer set, the same market data sources, and the same reference date must be applied to both companies for consistency. Any deviation in methodology between the two companies must be justified on the basis of the company's specific characteristics — not on the basis of producing a desired exchange ratio. The per-share fair value for each company is then determined as the weighted average of the three method outputs, with weights assigned based on the documented rationale.
5. Market Price Cross-Check (Listed Companies)
For listed companies, SEBI and stock exchanges require the derived exchange ratio to be compared against the ratio implied by market prices. The standard market price metrics are: the 30-day, 60-day, and 90-day volume-weighted average prices (VWAP) of both companies' shares, calculated as at the reference date. The implied market price ratio is then compared to the Valuation-derived share exchange ratio. Material divergence between the two — particularly where the Valuation-derived ratio is significantly less favourable to transferor shareholders than the market price ratio — is a primary basis for SEBI raising observations and requesting restatement or independent review.6. Swap Ratio Derivation and Sensitivity Analysis
Apply the swap ratio formula: per-share value of transferor ÷ per-share value of resulting company. Round to a manageable ratio (e.g., 3:1 or 7:3) as specified in the scheme — the rounding mechanism and fractional share treatment must be addressed in the scheme document. Conduct a sensitivity analysis on the derived ratio by varying the core inputs for both companies: WACC range, terminal growth rate, and CCM peer multiple range. The sensitivity analysis demonstrates the robustness of the derived exchange ratio across plausible assumption combinations and provides the NCLT and shareholders with the context to assess whether the final ratio is reasonable.7. Merger Valuation Report Preparation
The IBBI-registered valuer's report must include: an executive summary of the Valuation conclusions and the derived share exchange ratio; a detailed methodology section covering each approach applied to each company; documented assumptions for all projection inputs; the peer set used for CCM and the adjustments applied; the EV-to-equity bridge for each company; the sensitivity analysis tables; a section on VWAP cross-check (for listed companies); and the signed certification of the IBBI-registered valuer. The report must be self-contained — NCLT judges, SEBI officers, and opposing counsel must be able to understand and evaluate the methodology entirely from the written document.8. SEBI, Exchange Filing, and NCLT Submission
For listed companies: file the draft scheme (including the merger Valuation report) with the stock exchanges for review and SEBI no-objection. Timeline: typically 45–75 days from initial filing to SEBI no-objection letter. For both listed and unlisted companies: the Valuation report is included in the NCLT application as a mandatory exhibit. It is also summarised in the Explanatory Statement to shareholders — which must disclose the Valuation methodology, principal assumptions, and the basis for the share exchange ratio determination in a manner that enables shareholders to make an informed vote. The report must be available for inspection by shareholders and creditors at the registered offices of both companies prior to the scheme meeting.
How Does a Swap Ratio Worked Example Look?
The following illustrative example demonstrates the complete swap ratio calculation for a fictional merger between two Indian specialty chemicals companies. Every step — from individual company Valuation through VWAP cross-check to final swap ratio derivation — is shown at the level of detail that appears in a formal IBBI-registered valuer's report submitted to NCLT.
📋 Illustrative Example — ABC Speciality Chemicals / XYZ Chemicals Merger
Transaction: Merger of XYZ Speciality Chemicals Private Limited (transferor) into ABC Speciality Chemicals Private Limited (resulting company). Both unlisted. Scheme under Sections 230–232 of the Companies Act, 2013. Valuation date: 31 March 2026.
ABC Chemicals: Revenue Rs. 120 crore | EBITDA Rs. 22.8 crore | Net Debt Rs. 28.5 crore | Shares: 80 lakh
XYZ Chemicals: Revenue Rs. 65 crore | EBITDA Rs. 14.3 crore | Net Debt Rs. 12.0 crore | Shares: 50 lakh
Swap Ratio Valuation — ABC & XYZ Speciality Chemicals | Valuation Date: 31 March 2026
| Valuation Item | ABC Chemicals (Resulting) | XYZ Chemicals (Transferor) |
|---|---|---|
| A. INCOME APPROACH — DCF (WACC: ABC 14.6% | XYZ 15.2%) | ||
| Enterprise Value — DCF (Rs. Crore) | 220.6 | 114.2 |
| Less: Net Debt + Adjustments (Rs. Crore) | (34.7) | (15.8) |
| Equity Value — DCF (Rs. Crore) | 185.9 | 98.4 |
| Per-Share Value — DCF (Rs.) | 232.4 | 196.8 |
| B. MARKET APPROACH — CCM (EV/EBITDA Peer Multiple: 10.2x | DLOM: 20%) | ||
| Sector EV/EBITDA Multiple (listed peers) | 10.2x | 10.2x |
| Applied EBITDA (Rs. Crore) | 22.8 | 14.3 |
| Indicated EV — Pre-DLOM (Rs. Crore) | 232.6 | 145.9 |
| Less: DLOM at 20% | (46.5) | (29.2) |
| Enterprise Value — CCM (Rs. Crore) | 186.1 | 116.7 |
| Less: Net Debt + Adjustments | (34.7) | (15.8) |
| Per-Share Value — CCM (Rs.) | 189.2 | 201.8 |
| C. ASSET APPROACH — NAV | ||
| Fair Value of Net Assets (Rs. Crore) | 172.4 | 94.6 |
| Per-Share Value — NAV (Rs.) | 215.5 | 189.2 |
| D. WEIGHTED AVERAGE PER-SHARE VALUE (DCF 45% | CCM 40% | NAV 15%) | ||
| DCF Contribution (45%) | 104.6 | 88.6 |
| CCM Contribution (40%) | 75.7 | 80.7 |
| NAV Contribution (15%) | 32.3 | 28.4 |
| ✦ Weighted Per-Share Fair Value (Rs.) | 212.6 | 197.7 |
DLOM = Discount for Lack of Marketability. Both companies are unlisted; 20% DLOM applied based on liquidity analysis and expected time to liquidity event. DCF WACC: ABC 14.6% | XYZ 15.2% (XYZ carries higher CSRP due to customer concentration). Peer set: Sudarshan Chemical, Fine Organics, Atul Ltd, Vinati Organics, Galaxy Surfactants (illustrative). All Rs. figures in crore except per-share values.
📌 Swap Ratio Derivation
Swap Ratio = Per-Share Value of XYZ (Transferor) ÷ Per-Share Value of ABC (Resulting)
= Rs. 197.7 ÷ Rs. 212.6 = 0.930
Expressed as a practical ratio: 93 : 100 — for every 100 shares of XYZ Chemicals surrendered, shareholders receive 93 shares of ABC Chemicals.
Or equivalently: for every 1 share of XYZ Chemicals, shareholders receive 0.93 shares of ABC Chemicals. Fractional entitlements (arising where a shareholder's holding in XYZ is not exactly divisible to produce a whole number of ABC shares) will be settled in cash at Rs. 212.6 per ABC share, as specified in the scheme document.
Sensitivity Analysis — Exchange Ratio Across WACC and Multiple Assumptions
The sensitivity table below shows how the exchange ratio varies as the WACC differential between the two companies and the applied CCM multiple change across plausible ranges. The base case — WACC differential of 0.6% (XYZ at 15.2% vs. ABC at 14.6%) and EV/EBITDA multiple of 10.2x — is highlighted.
| WACC Differential (XYZ vs ABC) ↓ / EV/EBITDA Multiple → | 9.0x | 9.6x | 10.2x (Base) | 10.8x | 11.4x |
|---|---|---|---|---|---|
| No Differential (Same WACC) | 1.01 | 1.00 | 0.98 | 0.97 | 0.96 |
| 0.3% Differential (XYZ Higher) | 0.98 | 0.97 | 0.96 | 0.95 | 0.94 |
| 0.6% Differential ← Base | 0.95 | 0.94 | 0.93 ★ | 0.92 | 0.91 |
| 1.0% Differential (XYZ Higher) | 0.91 | 0.90 | 0.89 | 0.88 | 0.88 |
| 1.5% Differential (XYZ Higher) | 0.87 | 0.86 | 0.85 | 0.84 | 0.83 |
Green = favourable to XYZ (transferor) shareholders | Amber = mid range | Red = less favourable to XYZ shareholders | ★ = Base case exchange ratio 0.93. The sensitivity demonstrates that the base case ratio of 0.93:1 remains robust across the central range of assumptions, varying between 0.88 and 0.98 across all but the most extreme combinations.
Need a Swap Ratio Valuation for Your Merger?
Our IBBI-registered valuers deliver independent, SEBI-compliant merger Valuation reports for mergers, amalgamations, and demergers — including NCLT scheme support and fairness opinion services across all sectors.
How Does SEBI Review Swap Ratios for Listed Companies?
When either or both of the merging entities are listed on Indian stock exchanges, the share exchange ratio determination becomes subject to a substantially more rigorous regulatory review process — involving the stock exchanges, SEBI, and the requirement for an independent fairness opinion that goes beyond the standard Valuation report.
The Stock Exchange Filing and SEBI No-Objection Process
Under Regulation 37 of the SEBI LODR Regulations and SEBI's Circular on Schemes of Arrangement, a listed company must file the draft scheme with the stock exchange where it is listed before making any NCLT application. The exchange reviews the scheme against a specific checklist — which includes the independence and qualification of the Valuation firm, the methodology used to derive the merger ratio, the VWAP cross-check, and whether the scheme structure disproportionately benefits the promoter group. The exchange then forwards the scheme and its observations to SEBI. SEBI reviews the scheme and issues either a no-objection letter or raises specific observations that the company must address before proceeding.
VWAP Analysis — The Market Price Cross-Check
For listed companies, the SEBI-mandated VWAP analysis computes the volume-weighted average trading price of each company's shares over the 30-, 60-, and 90-day periods immediately preceding the valuation date. The ratio of the two companies' VWAP is then compared to the Valuation-derived exchange ratio. Where the Valuation-derived ratio is materially less favourable to the transferor company's public shareholders than the VWAP ratio, SEBI will typically raise an observation requiring the company to explain the divergence or revise the merger ratio. SEBI's position — consistently maintained across multiple scheme reviews — is that public shareholders of the transferor company should not receive a materially worse deal than what market prices would imply without a clear, documented Valuation-based justification.
The Fairness Opinion Requirement
Beyond the Valuation report produced by the IBBI-registered valuer, SEBI's Circular on Schemes of Arrangement requires the stock exchange to obtain an independent fairness opinion from its panel of registered valuers or investment bankers. This fairness opinion assesses whether the share exchange ratio as determined is fair to the shareholders of each company — with a particular focus on the public shareholders of listed entities. The fairness opinion is conceptually distinct from the Valuation report: the Valuation report establishes per-share values using defined methodologies, while the fairness opinion expresses a professional conclusion on whether the derived exchange ratio is fair when considered in the context of the overall transaction.
📋 SEBI Filing Timeline for Listed Company Schemes: Draft scheme filing with exchange → Exchange review (10–30 days) → Exchange forwards to SEBI → SEBI review period (up to 30 days) → SEBI no-objection letter (or observations requiring response) → NCLT application filed → NCLT convenes scheme meetings → Shareholders vote (75% majority required) → NCLT hearing → NCLT order sanctioning scheme. Total timeline from SEBI filing to NCLT order: typically 6–12 months for standard schemes, longer where SEBI raises substantive observations on swap ratio.
How Is Swap Ratio Determined in a Demerger?
A demerger — the separation of a business division or undertaking from the parent company into a separately listed or unlisted entity — also requires a share exchange ratio determination, but the mechanics differ from a merger. In a demerger, the parent company's shareholders receive shares of the demerged entity in proportion to their existing shareholding in the parent — and the rate at which they receive these new shares must be determined through an independent Valuation exercise.
The primary Valuation challenge in a demerger is the accurate separation of the demerged undertaking's value from the remaining parent's value. The IBBI-registered valuer must independently value: the demerged undertaking (the business being separated), the retained parent (the residual parent business post-demerger), and the combined parent pre-demerger — with the sum of the demerged undertaking and retained parent values cross-checking against the pre-demerger parent value. The demerger ratio is then the relationship between the demerged undertaking's per-share value and the parent's pre-demerger per-share value.
For listed parent companies, SEBI applies the same review process to demerger schemes as to merger schemes — including the VWAP cross-check and the requirement for the exchange ratio to be fair to public shareholders. For demergers involving the separation of a regulated business (e.g., separating a banking licence, an NBFC, or a telecom licence), additional regulatory approvals from the sector regulator (RBI, TRAI) may be required before NCLT. To understand the full range of scenarios requiring independent Valuation under Indian law, see our guide on when company Valuation is mandatory in India. Our company Valuation serviceshttps://elitevaluation.in/services/company-law-valuation-service/ and M&A Valuation guide cover the full spectrum of demerger and restructuring Valuation assignments.
What Are the Costliest Swap Ratio Valuation Mistakes?
After reviewing merger Valuation reports submitted in NCLT proceedings and SEBI scheme filings across multiple sectors, the following mistakes recur most frequently — and carry the highest regulatory, reputational, and shareholder-dispute risk.
❌ Mistake 1: Valuing on Different Reference Dates
Valuing the transferor and resulting company on different dates — even two months apart — introduces systematic inconsistency into the derived exchange ratio. Market conditions, interest rates, sector multiples, and each company's own financial position may have changed materially between the two dates. SEBI and NCLT require both valuations to share a single reference date. Using different dates is a compliance deficiency that provides a basis for any aggrieved shareholder to challenge the scheme.
❌ Mistake 2: Using a Single Valuation Method for Both Companies
Applying only DCF to both companies, or only EV/EBITDA multiples, limits the Valuation to a single lens — which is advisable to avoid, as SEBI and NCLT expect a multi-method approach. More importantly, where the two companies are at different stages of development or have different asset structures, using the same single method for both produces a systematically biased share exchange ratio. A holding company valued on DCF and a manufacturing company also valued on DCF — without NAV for the holding company — will misrepresent the relative per-share values. Method selection must be independently justified for each company.
❌ Mistake 3: Allowing Management to Influence Assumptions
The most common source of biased swap ratios is management influence on the Valuation assumptions — particularly revenue projections and WACC inputs — for the company whose per-share value management wants to optimise. A promoter group controlling both merging companies has an obvious incentive to maximise the resulting company's per-share value (where they hold more shares) and minimise the transferor company's per-share value (where they hold fewer). Independence of the Valuation process is the only safeguard against this — and it requires the IBBI-registered valuer to challenge and document the rationale for all material projection inputs, not to accept management inputs without scrutiny.
❌ Mistake 4: Ignoring Outstanding Convertibles in the Share Count
The per-share value must be computed on a fully diluted basis — including all outstanding convertible instruments, ESOPs, warrants, and optionally convertible debentures that could result in additional shares being issued. Using only the currently outstanding share count, without accounting for these potential dilutions, overstates the per-share value of the company with more convertibles outstanding. This error systematically favours one side of the exchange — typically the resulting company, if it has more convertibles outstanding. The scheme document must also specify how outstanding convertibles in the transferor company are treated post-merger. For mergers involving startups with complex cap structures and multiple convertible rounds, see our startup Valuation guide. Our share and securities Valuation services cover the full range of convertible instrument Valuation required in complex capital structures.
❌ Mistake 5: No Sensitivity Analysis in the Report
Presenting only a single-point exchange ratio without any sensitivity analysis implies false precision and does not meet professional standards. NCLT expects the Valuation report to demonstrate the robustness of the derived ratio by showing how it changes under varying assumptions. A sensitivity matrix — varying WACC and terminal growth rate for DCF, and varying the peer multiple for CCM — provides the court and shareholders with the context to assess whether the derived ratio is reasonable or highly dependent on optimistic assumptions.
❌ Mistake 6: Not Addressing Minority Discount Consistently
Where one or both companies have minority shareholders, the question of whether per-share values should be computed on a controlling-interest or minority-interest basis must be answered consistently for both companies. Applying a minority discount for one company but not the other produces a merger ratio that is biased in favour of the company treated on a controlling-interest basis. The scheme document must specify whether the exchange ratio is determined on a controlling basis — which is standard for merger accounting — and the Valuation report must be consistent with this specification.
Is Your Swap Ratio Report SEBI and NCLT Compliant?
Use this checklist to assess whether your merger Valuation report and scheme documentation meet current regulatory requirements. Items marked Priority are the most frequently scrutinised by SEBI inspectors and NCLT in contested scheme proceedings.
📌 Documents Required for a Swap Ratio Report in India
A complete swap ratio Valuation report filing must include: audited financial statements (3–5 years) of both companies, management projections and business plans, the draft scheme of arrangement, cap tables with all convertible instruments and ESOP details, material contracts and shareholder agreements, the IBBI-registered valuer's independence declaration, prior independent Valuations (if any), and — for listed companies — stock exchange filing confirmations and SEBI correspondence. The Explanatory Statement filed with NCLT must separately summarise the Valuation methodology, principal assumptions, and the basis for the derived share exchange ratio.
| Compliance Item | Status |
|---|---|
| Single valuation reference date used for both companies | Priority |
| IBBI-registered valuer appointed and independence declaration obtained | Priority |
| All three valuation approaches (DCF, CCM, NAV) applied to both companies | Priority |
| Weights assigned to each method documented and justified for each company | Priority |
| Per-share values computed on a fully diluted basis (including ESOPs, convertibles, warrants) | Required |
| Net debt bridge applied correctly — including Ind AS 116 lease liabilities, contingent liabilities | Required |
| VWAP analysis (30/60/90 days) conducted and documented for listed companies | Priority (Listed) |
| Divergence between valuation-derived ratio and VWAP ratio explained with documented rationale | Priority (Listed) |
| Sensitivity analysis on exchange ratio across WACC and multiple ranges included in report | Required |
| Treatment of fractional shares specified in scheme document | Required |
| SEBI draft scheme filed with stock exchange before NCLT application (listed companies) | Priority (Listed) |
| Valuation report summary disclosed in explanatory statement to shareholders | Required |
| Valuation report available for shareholder inspection before scheme meeting | Required |
| EPS and book value per share cross-checks documented as sanity validation | Best Practice |
| Tax neutrality conditions under Income Tax Act (Sections 2(1B) and 2(19AA)) reviewed | Best Practice |
📌 Documents Required for a Swap Ratio Report in India
A complete swap ratio Valuation report filing must include: audited financial statements (3–5 years) of both companies, management projections and business plans, the draft scheme of arrangement, cap tables with all convertible instruments and ESOP details, material contracts and shareholder agreements, the IBBI-registered valuer's independence declaration, prior independent Valuations (if any), and — for listed companies — stock exchange filing confirmations and SEBI correspondence. The Explanatory Statement filed with NCLT must separately summarise the Valuation methodology, principal assumptions, and the basis for the derived share exchange ratio.
Get an Independent Swap Ratio Valuation — IBBI Registered Valuer Certified
Whether your merger involves listed or unlisted companies, requires SEBI no-objection, or is proceeding before NCLT, our IBBI-registered valuers deliver defensible, fully documented merger Valuation reports that meet every regulatory and governance standard.
Closing Summary: Swap Ratio as a Governance Instrument
The swap ratio is not merely a mathematical output — it is the central governance decision in every merger and amalgamation. It determines how the value created by the combined entity is distributed between the two pre-merger shareholder bases, and it sets the terms on which thousands of shareholders — many of them minority investors with no voice in the negotiation — exchange their shares. The quality, independence, and rigour of the Valuation process that produces the exchange ratio is therefore the primary mechanism through which fairness is preserved in M&A transactions. An independently determined, methodology-based, and fully documented merger ratio — certified by a qualified IBBI-registered valuer — is the difference between a scheme that proceeds with regulatory confidence and one that becomes a contested proceeding before NCLT or an SEBI enforcement matter. At Elite Valuation, our IBBI-registered valuers bring the technical depth, regulatory awareness, and documentation discipline that swap ratio determination in India demands — across listed and unlisted companies, standard mergers, and complex multi-entity restructurings.
Frequently Asked Questions — Swap Ratio
CA Sagar Shah, Founder
Mr Sagar Shah is the Founder of Elite Valuation and leads the firm’s Valuation and Advisory practice. With over 15+ years of professional experience.
